The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.